LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 35933

Search options

  1. Article ; Online: The effect of Ding-kun-dan comparing with Marvelon on primary dysmenorrhea: A prospective, double-blind, multicenter, randomized controlled trial.

    Gan, Jingwen / Zhu, Shi-Yang / Ma, Xiao / Ding, Xue-Song / Deng, Yan / Wang, Yanfang / Sun, Ai-Jun

    Journal of ethnopharmacology

    2023  Volume 318, Issue Pt B, Page(s) 116975

    Abstract: Ethnopharmacological relevance: Ding-kun-dan (DKD), as one of well-known ... Aim of the study: To compare the effect of Ding-kun-dan (DKD) with Marvelon on relief of symptoms and ... 4: Conclusion: Ding-kun-dan is another available, effective and safe method for patients ...

    Abstract Ethnopharmacological relevance: Ding-kun-dan (DKD), as one of well-known traditional Chinese medicine (TCM), is considered as an effective prescription to regulate menstruation, benefit Qi and nourish the blood. Previous studies had showed that DKD could improve sex hormone levels, insulin resistance, metabolism abnormalities and regulate immunity in animal models with polycystic ovary syndrome or endometriosis, however, little study conducted to reveal its clinical efficacy in Primary Dysmenorrhea (PD).
    Aim of the study: To compare the effect of Ding-kun-dan (DKD) with Marvelon on relief of symptoms and change of serum pain-related factors in patients with primary dysmenorrhea.
    Materials and method: 136 patients with primary dysmenorrhea were randomly assigned to the DKD group (n = 73, take one tablet per day from 5th day of the menstrual cycle for 10 days every 28 days) and the Marvelon group (n = 63, take one tablet per day from 5th day of the menstrual cycle for 21 days every 28 days), the therapeutic effects were analyzed through evaluating the change of VAS scores, CMSS scores and the level of PGF
    Results: Both DKD and Marvelon could effectively relief pain and other associated symptoms at each visit (Baseline, 4
    Conclusion: Ding-kun-dan is another available, effective and safe method for patients with primary dysmenorrhea to choose, especially for those who are suffered from mild pain and/or contraindicated to hormonal agents.
    MeSH term(s) Female ; Humans ; Desogestrel/therapeutic use ; Dinoprostone ; Double-Blind Method ; Dysmenorrhea/drug therapy ; Dysmenorrhea/diagnosis ; Endometriosis ; Medicine, Chinese Traditional ; Prospective Studies
    Chemical Substances Desogestrel (81K9V7M3A3) ; Dinoprostone (K7Q1JQR04M)
    Language English
    Publishing date 2023-07-29
    Publishing country Ireland
    Document type Journal Article ; Multicenter Study ; Randomized Controlled Trial
    ZDB-ID 134511-4
    ISSN 1872-7573 ; 0378-8741
    ISSN (online) 1872-7573
    ISSN 0378-8741
    DOI 10.1016/j.jep.2023.116975
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The effect of Ding-kun-dan comparing with Marvelon on primary dysmenorrhea: A prospective, double-blind, multicenter, randomized controlled trial

    Gan, Jingwen / Zhu, Shi-yang / Ma, Xiao / Ding, Xue-song / Deng, Yan / Wang, Yanfang / Sun, Ai-jun

    Journal of Ethnopharmacology. 2024 Jan., v. 318 p.116975-

    2024  

    Abstract: Ding-kun-dan (DKD), as one of well-known traditional Chinese medicine (TCM), is considered ... conducted to reveal its clinical efficacy in Primary Dysmenorrhea (PD). To compare the effect of Ding-kun ... kun-dan is another available, effective and safe method for patients with primary dysmenorrhea ...

    Abstract Ding-kun-dan (DKD), as one of well-known traditional Chinese medicine (TCM), is considered as an effective prescription to regulate menstruation, benefit Qi and nourish the blood. Previous studies had showed that DKD could improve sex hormone levels, insulin resistance, metabolism abnormalities and regulate immunity in animal models with polycystic ovary syndrome or endometriosis, however, little study conducted to reveal its clinical efficacy in Primary Dysmenorrhea (PD). To compare the effect of Ding-kun-dan (DKD) with Marvelon on relief of symptoms and change of serum pain-related factors in patients with primary dysmenorrhea. 136 patients with primary dysmenorrhea were randomly assigned to the DKD group (n = 73, take one tablet per day from 5th day of the menstrual cycle for 10 days every 28 days) and the Marvelon group (n = 63, take one tablet per day from 5th day of the menstrual cycle for 21 days every 28 days), the therapeutic effects were analyzed through evaluating the change of VAS scores, CMSS scores and the level of PGF₂ₐ, PGE₂, PGF₂ₐ/PGE₂ and NO during the 12 weeks intervention. Both DKD and Marvelon could effectively relief pain and other associated symptoms at each visit (Baseline, 4ᵗʰ week, 8ᵗʰ week and 12ᵗʰ week). Although Marvelon was significantly superior to DKD in reducing VAS scores, the total CMSS, CMSS severity and duration scores at each posttreatment follow-up (P < 0.01), VAS scores in the DKD group decreased significantly over time while scores in the COC group only dropped rapidly after the first two months of treatment. Efficacy gap between two interventions continuously narrowed over time and the efficacy of DKD became non-inferior at the 12ᵗʰ week compared to that of Marvelon (the difference between groups, – 0.78%; 95% confidence interval (CI), −13.67%–12.75%; non-inferiority margin, 15%). DKD group had better efficacy on mild pain compared to that of the COC group with no statistical difference (75% VS 61.9%, P > 0.05). DKD and Marvelon could effectively reduce PGF₂ₐ, PGE₂ and higher PGF₂ₐ/PGE₂ in patients with PD. There was no statistical difference in the level of PGF₂ₐ, PGE₂, PGF₂ₐ/PGE₂ and NO between DKD and Marvelon group at each follow-up. No serious adverse effect was observed. Ding-kun-dan is another available, effective and safe method for patients with primary dysmenorrhea to choose, especially for those who are suffered from mild pain and/or contraindicated to hormonal agents.
    Keywords Oriental traditional medicine ; adverse effects ; animals ; blood serum ; confidence interval ; endometriosis ; immunity ; insulin resistance ; menstruation ; metabolism ; pain ; polycystic ovary syndrome ; therapeutics ; Primary dysmenorrhea ; Ding-kun-dan ; Marvelon ; VAS ; CMSS ; PGF2a ; PGE2 ; PGF2a/PGE2
    Language English
    Dates of publication 2024-01
    Publishing place Elsevier B.V.
    Document type Article ; Online
    ZDB-ID 134511-4
    ISSN 1872-7573 ; 0378-8741
    ISSN (online) 1872-7573
    ISSN 0378-8741
    DOI 10.1016/j.jep.2023.116975
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  3. Article: Kun-Dan Decoction Ameliorates Insulin Resistance by Activating AMPK/mTOR-Mediated Autophagy in High-Fat Diet-Fed Rats.

    Su, Zuqing / Zeng, Kexue / Feng, Bing / Tang, Lipeng / Sun, Chaoyue / Wang, Xieqi / Li, Caiyun / Zheng, Guangjuan / Zhu, Ying

    Frontiers in pharmacology

    2021  Volume 12, Page(s) 670151

    Abstract: Background: ...

    Abstract Background:
    Language English
    Publishing date 2021-05-28
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2587355-6
    ISSN 1663-9812
    ISSN 1663-9812
    DOI 10.3389/fphar.2021.670151
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: The Role of Traditional Chinese Formula Ding-Kun Pill (DKP) in Expected Poor Ovarian Response Women (POSEIDON Group 4) Undergoing

    Song, Jing-Yan / Gao, Dan-Dan / Cao, Xian-Ling / Xiang, Shan / Chen, Yan-Hua / Teng, Yi-Li / Li, Xiu-Fang / Liu, Hai-Ping / Wang, Fu-Xin / Zhang, Bin / Xu, Li-Hua / Zhou, Li / Huang, Xiang-Hong / Sun, Zhen-Gao

    Frontiers in endocrinology

    2021  Volume 12, Page(s) 675997

    Abstract: Objective: The primary objective of the study was to assess traditional Chinese formula DKP supplementation in terms of efficacy and safety on reproductive outcomes of expected poor ovarian responder (POR, POSEIDON Group 4) undergoing : Design setting ...

    Abstract Objective: The primary objective of the study was to assess traditional Chinese formula DKP supplementation in terms of efficacy and safety on reproductive outcomes of expected poor ovarian responder (POR, POSEIDON Group 4) undergoing
    Design setting and participants: Women eligible for IVF-ET were invited to participate in this randomized, double-blind, placebo-controlled, superiority trial at academic fertility centers of ten public hospitals in Chinese Mainland. A total of 462 patients (35-44 years) equally divided between DKP and placebo groups with antral follicle count (AFC) <5 or anti-müllerian hormone (AMH) <1.2 ng/ml were randomized.
    Interventions: All participants were given DKP or 7 g placebo twice daily on the previous menstrual cycle day 5 until oocyte retrieval, which took approximately 5 to 6 weeks.
    Main outcome measure: The primary outcome was the ongoing pregnancy defined as more than 20 gestational weeks of an intrauterine living fetus confirmed by pelvic ultrasonography.
    Results: Demographic characteristics were equally distributed between the study populations. Intention-to-treat (ITT) analysis revealed that ongoing pregnancy rate (OPR) was not significantly different between DKP and placebo groups [26.4% (61/231) versus 24.2% (56/231); relative risk (RR) 1.09, 95% confidence interval (CI) 0.80 to 1.49,
    Conclusion: This well-designed randomized controlled trial (RCT) offers new high-quality evidence to supplement existing retrospective literature concerning DKP performance in expected PORs. DKP could be recommended as a safe and natural remedy for expected PORs (aged 35-37 years) who fulfill the POSEIDON group 4 criteria. However, additional interventional clinical studies are undoubtedly required to be conducted in the future to validate this hypothesis.
    Clinical trial registration: www.chictr.org.cn, identifier ChiCTR1900026614.
    MeSH term(s) Adult ; China/epidemiology ; Double-Blind Method ; Embryo Transfer/methods ; Female ; Fertilization in Vitro/drug effects ; Follow-Up Studies ; Humans ; Infertility, Female/drug therapy ; Infertility, Female/epidemiology ; Medicine, Chinese Traditional/methods ; Oocyte Retrieval ; Ovulation Induction/standards ; Pregnancy ; Pregnancy Rate ; Prognosis
    Language English
    Publishing date 2021-06-17
    Publishing country Switzerland
    Document type Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2021.675997
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Effects of Gui Zhu Yi Kun formula on the P53/AMPK pathway of autophagy in granulosa cells of rats with polycystic ovary syndrome.

    Xing, Yu / Liu, Yan-Xia / Liu, Xin / Wang, Shu-Lin / Li, Ping / Lin, Xiao-Hua / Sui, Cong-Lu / Xu, Cai / Qi, Bing / Tong, Qing

    Experimental and therapeutic medicine

    2017  Volume 13, Issue 6, Page(s) 3567–3573

    Abstract: ... with the traditional Chinese medicine formula Gui Zhu Yi Kun formula (GZYKF), in the treatment of polycystic ovary syndrome (PCOS ...

    Abstract The aim of the present study was to investigate the molecular mechanism associated with the traditional Chinese medicine formula Gui Zhu Yi Kun formula (GZYKF), in the treatment of polycystic ovary syndrome (PCOS). In this study, granulosa cells (GCs) of rats with PCOS were cultured and treated with testosterone propionate (TP) alone or with serum from rats treated with different doses of GZYKF. The effect of TP on cell growth was assayed using the MTT method. Expression levels of Beclin-1, light chain (LC)3, mechanistic target of rapamycin (mTOR), tumor suppressor p53 (p53), adenosine monophosphate-activated protein kinase (AMPK), sestrin2 and tuberous sclerosis protein 1/2 were evaluated using quantitative polymerase chain reaction and western blotting. It was demonstrated that TP increased the expression of Beclin-1 and LC3, whereas GZYKF significantly decreased the TP-induced expression of Beclin-1 (P<0.01). Additionally, GCs treated with GZYKF exhibited significant increases in mTOR, phosphorylated mTOR and AMPKα expression levels, and significant reductions in p53 and sestrin2 expression levels were observed. In conclusion, the findings of the present study suggest that a reduction in ovarian GCs in rats with PCOS may be associated with GC autophagy. Furthermore, the effects of GZYKF in mediating the p53/AMPK pathway may inhibit GC autophagy, which suggests a possible novel mechanism underlying the treatment of PCOS with GZYKF.
    Language English
    Publishing date 2017-04-26
    Publishing country Greece
    Document type Journal Article
    ZDB-ID 2683844-8
    ISSN 1792-1015 ; 1792-0981
    ISSN (online) 1792-1015
    ISSN 1792-0981
    DOI 10.3892/etm.2017.4384
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The Role of Traditional Chinese Formula Ding-Kun Pill (DKP) in Expected Poor Ovarian Response Women (POSEIDON Group 4) Undergoing In Vitro Fertilization-Embryo Transfer

    Jing-Yan Song / Dan-Dan Gao / Xian-Ling Cao / Shan Xiang / Yan-Hua Chen / Yi-Li Teng / Xiu-Fang Li / Hai-Ping Liu / Fu-Xin Wang / Bin Zhang / Li-Hua Xu / Li Zhou / Xiang-Hong Huang / Zhen-Gao Sun

    Frontiers in Endocrinology, Vol

    A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

    2021  Volume 12

    Abstract: ObjectiveThe primary objective of the study was to assess traditional Chinese formula DKP supplementation in terms of efficacy and safety on reproductive outcomes of expected poor ovarian responder (POR, POSEIDON Group 4) undergoing in vitro ... ...

    Abstract ObjectiveThe primary objective of the study was to assess traditional Chinese formula DKP supplementation in terms of efficacy and safety on reproductive outcomes of expected poor ovarian responder (POR, POSEIDON Group 4) undergoing in vitro fertilization-embryo transfer (IVF-ET).Design, Setting, and ParticipantsWomen eligible for IVF-ET were invited to participate in this randomized, double-blind, placebo-controlled, superiority trial at academic fertility centers of ten public hospitals in Chinese Mainland. A total of 462 patients (35–44 years) equally divided between DKP and placebo groups with antral follicle count (AFC) <5 or anti-müllerian hormone (AMH) <1.2 ng/ml were randomized.InterventionsAll participants were given DKP or 7 g placebo twice daily on the previous menstrual cycle day 5 until oocyte retrieval, which took approximately 5 to 6 weeks.Main Outcome MeasureThe primary outcome was the ongoing pregnancy defined as more than 20 gestational weeks of an intrauterine living fetus confirmed by pelvic ultrasonography.ResultsDemographic characteristics were equally distributed between the study populations. Intention-to-treat (ITT) analysis revealed that ongoing pregnancy rate (OPR) was not significantly different between DKP and placebo groups [26.4% (61/231) versus 24.2% (56/231); relative risk (RR) 1.09, 95% confidence interval (CI) 0.80 to 1.49, P = 0.593]. No significant differences between groups were observed for the secondary outcomes. The additional per protocol (PP) analysis was in line with ITT results: OPR in DKP group was 27.2% (61/224) versus 24.1% (55/228) in placebo group [RR 1.13, 95%CI (0.82 to 1.55), P = 0.449]. After subgroup analysis the findings concluded that POR population of 35–37 years had a significantly higher OPR after 5–6 weeks of oral DKP (41.8%, 33/79) versus placebo (25.4%, 18/71) [RR 1.65, 95% CI (1.02 to 2.65), P = 0.034, P for interaction = 0.028].ConclusionThis well-designed randomized controlled trial (RCT) offers new high-quality evidence to supplement existing retrospective literature concerning DKP performance in expected PORs. DKP could be recommended as a safe and natural remedy for expected PORs (aged 35–37 years) who fulfill the POSEIDON group 4 criteria. However, additional interventional clinical studies are undoubtedly required to be conducted in the future to validate this hypothesis.Clinical Trial Registrationwww.chictr.org.cn, identifier ChiCTR1900026614.
    Keywords POSEIDON criteria ; low prognosis ; Ding-Kun Pill ; traditional Chinese medicine ; poor ovarian response ; in vitro fertilization-embryo transfer ; Diseases of the endocrine glands. Clinical endocrinology ; RC648-665
    Subject code 610
    Language English
    Publishing date 2021-06-01T00:00:00Z
    Publisher Frontiers Media S.A.
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Qi-Qin Accretionary Belt in Central China Orogen: accretion by trench jam of oceanic plateau and formation of intra-oceanic arc in the Early Paleozoic Qin-Qi-Kun Ocean.

    Song, Shuguang / Yang, Liming / Zhang, Yuqi / Niu, Yaoling / Wang, Chao / Su, Li / Gao, Yanlin

    Science bulletin

    2017  Volume 62, Issue 15, Page(s) 1035–1038

    Language English
    Publishing date 2017-07-25
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2816140-3
    ISSN 2095-9281 ; 2095-9273
    ISSN (online) 2095-9281
    ISSN 2095-9273
    DOI 10.1016/j.scib.2017.07.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Book: Ji ben yi liao bao xian zhi du de gai ge yu fan pin kun yan jiu

    Wang, Feiyue

    2014  

    Author's details Wang Feiyue zhu
    MeSH term(s) Insurance, Health/economics ; Health Care Reform ; Poverty
    Keywords China
    Language Chinese
    Size 2, 2, 274 p. :, ill.
    Edition Di 1 ban.
    Publisher Zhongguo she hui ke xue chu ban she
    Publishing place Beijing
    Document type Book
    ISBN 9787516151365 ; 751615136X
    Database Catalogue of the US National Library of Medicine (NLM)

    More links

    Kategorien

  9. Book: Kun chong sheng wu hua xue

    Wang, Yinchang

    2001  

    Author's details Wang Yinchang zhu bian
    Keywords Insects/Physiology. ; Insect biochemistry.
    Language Chinese
    Size 2, 11, 488 p. :, ill. ;, 27 cm.
    Edition Di 1 ban.
    Publisher Zhongguo nong ye chu ban she ; Xin hua shu dian Beijing fa xing suo fa xing
    Publishing place Beijing shi
    Document type Book
    ISBN 7109065626 ; 9787109065628
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  10. Article: Evaluation of Dry Medium (Sanita-Kun) for Enumeration of Coliforms and Escherichia coli in Milk, Ice Cream, Ham, and Codfish Fillet

    Park, J.H., Yeungnam University, Gyeongsan, Republic of Korea / Wang, Xin Yue, Yeungnam University, Gyeongsan, Republic of Korea / Lee, J.S., Yeungnam University, Gyeongsan, Republic of Korea / Kim, M.H., Yeungnam University, Gyeongsan, Republic of Korea

    Food Science and Biotechnology

    (Dec 2012)  Volume v. 21, Issue (6), Page(s) p. 1789–1793

    Abstract: This study was performed to compare the efficiency and accuracy of Sanita-Kun dry medium ... differences in enumerating coliforms and E. coli. In addition, the Sanita-Kun method was easier to count ... microbial load than the Petrifilm method. Therefore, we concluded that the Sanita-Kun method can be used ...

    Abstract This study was performed to compare the efficiency and accuracy of Sanita-Kun dry medium with those of conventional culture and Petrifilm dry medium methods for enumerating coliforms and Escherichia coli in milk, ice cream, ham, and codfish fillet. All 3 methods showed high correlations each other and no significant differences in enumerating coliforms and E. coli. In addition, the Sanita-Kun method was easier to count microbial load than the Petrifilm method. Therefore, we concluded that the Sanita-Kun method can be used as an alternative to conventional culture and Petrifilm methods for the analysis of coliforms and E. coli in milk, ice cream, ham, and codfish fillet products.
    Keywords ESCHERICHIA COLI ; ESCHERICHIA COLI ; ESCHERICHIA COLI
    Language English
    Document type Article
    ISSN 1226-7708
    Database AGRIS - International Information System for the Agricultural Sciences and Technology

    More links

    Kategorien

To top